Dr. Dubin and Dr. Reh weigh in on the impact of Consumer Advertising for medications and how that affects what medication is prescribed to patients.
Douglas D. Reh, MD, director of clinical research at Centers for Advanced ENT Care, LLC, in Baltimore, said that DTCA can give the drugs that he prescribes credibility with patients. Considering the record amount of money spent on advertising Dupixent, he says it’s not surprising that Dupixent is the top drug that his patients ask about.
“Providers should educate patients on why they did or didn’t prescribe a drug initially or why it may or may not be the right treatment for them.” —Marc G. Dubin, MD
FULL ARTICLE BELOW